In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues | 2.1 | 0.2 | 0.0 | 0.0 |
Revenue growth | 953.0% | | | |
Cost of goods sold | 8.8 | 2.7 | 0.0 | 0.0 |
Gross profit | -6.7 | -2.5 | 0.0 | 0.0 |
Gross margin | -316.8% | -1268.5% | | |
Selling, general and administrative | 42.0 | 35.3 | 9.6 | 2.7 |
Research and development | 110.4 | 58.3 | 12.6 | 9.3 |
Other operating expenses | 0.0 | 0.7 | | |
EBITDA [+] | -157.8 | -95.9 | -21.3 | -11.0 |
EBITDA growth | 64.5% | 349.7% | 94.4% | |
EBITDA margin | -7493.9% | -47971.5% | | |
Depreciation and amortization | 1.2 | 0.9 | 0.9 | 1.0 |
EBIT [+] | -159.0 | -96.8 | -22.2 | -12.0 |
EBIT growth | 64.3% | 336.5% | 84.9% | |
EBIT margin | -7552.2% | -48413.5% | | |
Non-recurring items [+] | 0.0 | -0.7 | | |
Asset impairment | 0.0 | -0.7 | | |
Interest expense, net [+] | -5.7 | -0.8 | 5.5 | 3.3 |
Interest expense | | | 5.5 | 3.3 |
Interest income | 5.7 | 0.8 | 0.0 | |
Other income (expense), net [+] | -0.1 | -0.7 | 351.8 | 1.1 |
Gain (loss) on debt retirement | | | -10.2 | |
Unrealized gain/loss on derivatives | | | 361.9 | 1.1 |
Change in fair value of warrants | | | 363.3 | |
Other | 0.0 | | 0.0 | 0.0 |
Pre-tax income | -153.4 | -96.0 | 324.1 | -14.1 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -153.4 | -96.0 | 324.1 | -14.1 |
Net margin | -7281.9% | -48024.0% | | |
|
Basic EPS [+] | ($0.87) | ($0.56) | $3.11 | ($0.16) |
Growth | 56.8% | -118.0% | -2007.4% | |
Diluted EPS [+] | ($0.87) | ($0.56) | $2.88 | ($0.16) |
Growth | 56.8% | -119.4% | -1867.6% | |
|
Shares outstanding (basic) [+] | 175.4 | 172.2 | 104.3 | 86.6 |
Growth | 1.8% | 65.1% | 20.4% | |
Shares outstanding (diluted) [+] | 175.4 | 172.2 | 112.6 | 86.6 |
Growth | 1.8% | 53.0% | 29.9% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |